Medical Marijuana Inc.'s HempMedsPX Joins A4M as Platinum Elite Sponsor

Medical Marijuana Inc.'s HempMedsPX Joins A4M as Platinum Elite Sponsor

HempMedsPX to Participate in the American Academy of Anti-Aging Medicine's
(A4M) 2014 Conferences; Awareness of CBD-Rich Hemp Oil Products Reaches More
Than 26,000 Members

SAN DIEGO, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc.(OTC
Pink:MJNA) and HempMedsPX™ – a corporate portfolio company of Medical
Marijuana Inc. and the exclusive master distributor and contracted marketing
company for CannaVest Corp. and Medical Marijuana, Inc. – are pleased to
announce that the American Academy of Anti-Aging Medicine (A4M) has approved
and is actively promoting HempMedsPX™ as a new Platinum Elite Sponsor on both
the A4M and websites. The A4M is a 501(c)3 non-profit
organization with more than 26,000 members including physicians, scientists,
and governmental officials in over 120 nations. The A4M seeks to disseminate
information concerning innovative science and research as well as treatment
modalities designed to prolong the human lifespan. The online information
portal for the A4M members,, is a leading non-profit source of
trusted, non-commercial health information for doctors and the general public.

Medical Marijuana Inc Logo

HempMedsPX logo

The A4M is dedicated to the advancement of technology to detect, prevent, and
treat aging-related disease, and to promote research into methods to slow and
optimize the human aging process. The A4M is also dedicated to educating
physicians, scientists, and members of the public on biomedical sciences,
cutting-edge technologies, and anti-aging issues. 85% of A4M's membership is
physicians, and the organization is a destination for Board (The American
Board of Anti-Aging and Regenerative Medicine – ABAARM) and Diplomate (The
American Board of Anti-Aging Health Practitioners – ABAAHP) certifications, as
well as a variety of additional Anti-Aging medicine accreditation programs for
healthcare practitioners.

Cannabinoids have been found to have antioxidant properties.The US Department
of Health and Human Services (HHS) was awarded United States Patent #6,630,507
for CBD and other cannabinoids on Oct. 7, 2003. 

The greatest benefit of A4M Platinum Elite Sponsorship for Medical Marijuana
Inc. and HempMedsPX™ is the access to governmental decision-makers,
groundbreaking scientists, and innovative physicians who have the ability to
medically and scientifically evaluate and recommend CBD-rich hemp oil products
globally. A variety of market opportunities defined by the A4M include:

  oThe anti-aging market is estimated to be worth $292 billion globally by
  o10% of the world's population is aged 60+ today, and is expected to
    represent 22% by 2050.
  oThe global nutraceutical market is projected to exceed $243 billion by
    -- The current US nutraceutical market is valued at $17.1 billion.
  oSixty percent (60%) of Americans aged 65+ are pursuing anti-aging
    interventions, including hormone replacement therapies and dietary
  oDietary supplement sales were $25 billion in 2010.
    -- Thirty-three percent (33%) of adults take supplements on the specific
    advice of their doctor.

"CBD is recognized as a powerful antioxidant by the U.S. government's patent
on cannabidiol and other cannabinoids," says Michelle Sides, COO of Medical
Marijuana Inc. "HempMedsPX™ is blazing a trail as the front-runner in both the
global anti-aging and nutraceutical markets by providing the A4M's 26,000
doctors and scientists with the latest information on the antioxidant
properties of the world's purest and richest CBD hemp oil products. Our
efforts to inform the public about CBD-rich hemp oil products are
significantly accelerated through our newfound alliance with the A4M. We are
extremely honored to be a Platinum Elite Sponsor of the A4M organization, and
we look forward to actively participating in a full slate of conferences in

Throughout the year, HempMedsPX™ will exhibit and promote cannabidiol
(CBD)-rich hemp oil products to tens of thousands of A4M members at the
organization's conferences including:

  *March 13-16: BHRT Symposium / Fellowship – San Francisco
  *April 4-6: Commercial Workshop / BHRT Symposium / Fellowship – Denver
  *May 15-17: Commercial Workshop – Orlando
  *September 10-13: BHRT Symposium / Fellowship – Phoenix
  *October 16-18: Fellowship Modules and IV Symposium – New Orleans
  *December 11-13: Commercial Workshop – Las Vegas

The A4M is comprised of over 26,000 members from 120 nations worldwide, as

  o85% are physicians (MD, DO, MBBS)
  o12% are scientists, researchers, and healthcare practitioners; and
  o3% are governmental officials, members of the working press and general

The disciplines of the A4M physician members are approximately:

  oFamily Practice, 23%
  oGeneral Medicine, 15%
  oEndocrinology, 11%
  oInternal Medicine, 8%
  oDermatology, 8%
  oPlastic Surgery, 6%
  oCardiology, 8%
  oDoctors of Osteopathy (D.O.), 6%
  oOB-GYN, 5%
  oSports Medicine, 4%
  oOrthopedics, 2%
  oEmergency Medicine, 2%
  oDoctors of Chiropractic (D.C.), 2%

HempMedsPX™ proudly represents the world's first innovative lines of CBD-rich
hemp oil products. On February 9^th, HempMedsPX™ continued to establish the
Company's brand recognition by representing the winner of the
globally-renowned 2014 High Times Cannabis Cup competition in Los Angeles for
Highest CBD Concentrate. This extremely competitive international judging
event featured entries by the most prominent growers, breeders and producers
of cannabis and cannabis products.Other significant industry accolades
include first place awards for Highest CBD Concentrate at the 2013 High Times
Cannabis Cup competition in Amsterdam, the2013 Seattle High Times Cannabis
Cup,and the2013 Michigan Medical Marijuana Conference "Green Cup"contests.

HempMedsPX™'s primary message to the public is that industrial hemp-derived
CBD is non-psychoactive, is readily available online, and is legal throughout
the United States and in more than forty countries. For more information on
CBD-rich hemp oil products, please visit:


Real Scientific Hemp Oil




About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their
integrity and entrepreneurial spirit. We strive to create awareness within our
industry, develop environmentally-friendly, economically sustainable
businesses, while increasing shareholder value. For more information, please
visit the company's website at:

About HempMedsPX

HempMedsPXoffers mainstream marketing, sales, customer service, and logistics
for the cannabis industry.HempMedsPXis a corporate portfolio company
ofMedical Marijuana, Inc.(OTC Pink:MJNA) and the exclusivemaster
distributor and contracted marketing company forCannaVest Corp.(OTC:CANV)
andMedical Marijuana Inc.In addition to handling sales and
distribution,HempMedsPXis the communication hub for the Medical Marijuana
Inc. portfolio of companies.

About CannaVest Corp.

CannaVest in the business of investing and developing hemp-based
businesses.CannaVest Corp.also develops, produces, markets and sells
end-consumer products to the nutraceutical industry containing the hemp plant
extract, cannabidiol (CBD). Additionally, the company resells—to third
parties—raw product acquired byCannaVest Corp.pursuant to the company's
supply international relationships.CannaVest Corp.seeks to take advantage of
an emerging worldwide trend to re-energize the production of industrial hemp
and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are
natural constituents of the hemp plant, and CBD is derived from hemp stalk and
seed. Additional information is available fromOTCMarkets.comor by


These statements have not been evaluated by the FDA and are not intended to
diagnose, treat or cure any disease.


This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material contains
statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of Medical Marijuana, Inc. to be materially different from the statements made


Medical Marijuana, Inc. does not sell or distribute any products that are in
violation of the United States Controlled Substances Act (US.CSA). The company
does grow, sell and distribute hemp-based products and are involved with
Federally Legal Distribution of Medical Marijuana-based products within
certain international markets. Cannabidiol is a natural constituent of hemp

CONTACT: For further information, please contact:
         Investor relations contact:
         Stuart T. Smith
         SmallCapVoice.Com, Inc.
         P. 512-267-2430
         Corporate Contact:
         Medical Marijuana, Inc.
         Toll Free: 888-OTC-MJNA (888-682-6562)

Medical Marijuana Inc Logo
Press spacebar to pause and continue. Press esc to stop.